TFC Financial Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503 | Buy |
+4
| New | +$503 | ﹤0.01% | 679 |
|
|
2024
Q3 | – | Sell |
-4
| Closed | -$551 | – | 1066 |
|
|
2024
Q2 | $551 | Buy |
4
+3
| +300% | +$413 | ﹤0.01% | 623 |
|
|
2024
Q1 | $138 | Buy |
+1
| New | +$138 | ﹤0.01% | 781 |
|
|
2023
Q2 | – | Sell |
-160
| Closed | -$16.2K | – | 715 |
|
|
2023
Q1 | $16.2K | Buy |
+160
| New | +$16.2K | ﹤0.01% | 330 |
|